These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19093031)

  • 21. HESX1- and TCF3-mediated repression of Wnt/β-catenin targets is required for normal development of the anterior forebrain.
    Andoniadou CL; Signore M; Young RM; Gaston-Massuet C; Wilson SW; Fuchs E; Martinez-Barbera JP
    Development; 2011 Nov; 138(22):4931-42. PubMed ID: 22007134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ectopic posterior pituitary lobe and periventricular heterotopia: cerebral malformations with the same underlying mechanism?
    Mitchell LA; Thomas PQ; Zacharin MR; Scheffer IE
    AJNR Am J Neuroradiol; 2002 Oct; 23(9):1475-81. PubMed ID: 12372734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of the PROP1 and HESX1 genes in patients with septo-optic dysplasia and/or pituitary hormone deficiency.
    Cruz JB; Nunes VS; Clara SA; Perone D; Kopp P; Nogueira CR
    Arq Bras Endocrinol Metabol; 2010; 54(5):482-7. PubMed ID: 20694410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Natural course of septo-optic dysplasia: retrospective analysis of 20 cases].
    León-Gonzalez M; García-Peñas JJ; Puertas-Bordallo D; López-Pino MA; Argente-Oliver J; Cantarín-Extremera V
    Rev Neurol; 2012 Mar; 54(6):321-31. PubMed ID: 22403144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The homeobox gene Hesx1 is required in the anterior neural ectoderm for normal forebrain formation.
    Martinez-Barbera JP; Rodriguez TA; Beddington RS
    Dev Biol; 2000 Jul; 223(2):422-30. PubMed ID: 10882526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel HESX1 mutations associated with a life-threatening neonatal phenotype, pituitary aplasia, but normally located posterior pituitary and no optic nerve abnormalities.
    Sobrier ML; Maghnie M; Vié-Luton MP; Secco A; di Iorgi N; Lorini R; Amselem S
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4528-36. PubMed ID: 16940453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Septo-optic dysplasia - novel insights into the aetiology.
    Kelberman D; Dattani MT
    Horm Res; 2008; 69(5):257-65. PubMed ID: 18259104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of the murine homeobox gene Hesx1 leads to a posterior transformation of the anterior forebrain.
    Andoniadou CL; Signore M; Sajedi E; Gaston-Massuet C; Kelberman D; Burns AJ; Itasaki N; Dattani M; Martinez-Barbera JP
    Development; 2007 Apr; 134(8):1499-508. PubMed ID: 17360769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics of septo-optic dysplasia.
    Kelberman D; Dattani MT
    Pituitary; 2007; 10(4):393-407. PubMed ID: 17587179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into septo-optic dysplasia.
    Saranac L; Gucev Z
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):123-7. PubMed ID: 24802313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Septo-optic dysplasia.
    Fard MA; Wu-Chen WY; Man BL; Miller NR
    Pediatr Endocrinol Rev; 2010 Sep; 8(1):18-24. PubMed ID: 21037540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcription factors regulating pituitary development.
    Parks JS; Brown MR
    Growth Horm IGF Res; 1999 Jun; 9 Suppl B():2-8; discussion 8-11. PubMed ID: 10549299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel human pathological mutations. Gene symbol: HESX1. Disease: septo-optic dysplasia.
    Mueller OT; Coovadia A
    Hum Genet; 2010 Apr; 127(4):478-9. PubMed ID: 21488242
    [No Abstract]   [Full Text] [Related]  

  • 34. Hesx1 gene in midline cerebral defects.
    Antonini SR; Grecco Filho AS; Elias LL; Moreira AC; de Castro M
    J Pediatr; 2001 Nov; 139(5):754. PubMed ID: 11713462
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia.
    Raivio T; Avbelj M; McCabe MJ; Romero CJ; Dwyer AA; Tommiska J; Sykiotis GP; Gregory LC; Diaczok D; Tziaferi V; Elting MW; Padidela R; Plummer L; Martin C; Feng B; Zhang C; Zhou QY; Chen H; Mohammadi M; Quinton R; Sidis Y; Radovick S; Dattani MT; Pitteloud N
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E694-9. PubMed ID: 22319038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Auxological, ophthalmological, neurological and MRI findings in 25 Austrian patients with septo-optic dysplasia (SOD). Preliminary data.
    Riedl SW; Müllner-Eidenböck A; Prayer D; Bernert G; Frisch H
    Horm Res; 2002; 58 Suppl 3():16-9. PubMed ID: 12435890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dkk1-dependent inhibition of Wnt signaling activates Hesx1 expression through its 5' enhancer and directs forebrain precursor development.
    Matsuda K; Kondoh H
    Genes Cells; 2014 May; 19(5):374-85. PubMed ID: 24520934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural pituitary abnormalities associated with CHARGE syndrome.
    Gregory LC; Gevers EF; Baker J; Kasia T; Chong K; Josifova DJ; Caimari M; Bilan F; McCabe MJ; Dattani MT
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E737-43. PubMed ID: 23526466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNMT1 interacts with the developmental transcriptional repressor HESX1.
    Sajedi E; Gaston-Massuet C; Andoniadou CL; Signore M; Hurd PJ; Dattani M; Martinez-Barbera JP
    Biochim Biophys Acta; 2008 Jan; 1783(1):131-43. PubMed ID: 17931718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine disorders in septo-optic dysplasia (De Morsier syndrome)--evaluation and follow up of 18 patients.
    Willnow S; Kiess W; Butenandt O; Dorr HG; Enders A; Strasser-Vogel B; Egger J; Schwarz HP
    Eur J Pediatr; 1996 Mar; 155(3):179-84. PubMed ID: 8929724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.